Patient Safety- Clinical

p3

Antithrombotic Therapies in Spine Surgery

Efficacy in Deep Vein Thrombosis Prevention with Extended Mechanical Compression Device Therapy and Prophylaxis Aspirin Following Total Knee Arthroplasty.

The DVT rate for the post-discharge protocol of Aspirin and Portable Mechanical Compression therapy group was 0%. The DVT rate for the post-discharge protocol of just Aspirin group was 23.1%

Authors: Seung-Beom Han, MD, PhDa, Yong In, MD, PhDb, Kwang Jun Oh

DVT in Spine Surgery Patients

Antithrombotic Therapy and
Prevention of Thrombosis

In patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA), we recommend use of one of the following for a minimum of 10 to 14 days rather than no antithrombotic prophylaxis: low-molecular-weight heparin (LMWH), fondaparinux, apixaban, dabigatran, rivaroxaban, low-dose unfractionated heparin (LDUH), adjusted-dose vitamin K antagonist (VKA), aspirin (all Grade 1B), or an intermittent pneumatic compression device (IPCD) (Grade 1C).

Authors: Seung-Beom Han, MD, PhDa, Yong In, MD, PhDb, Kwang Jun Oh

balance-beach-freedom-002
backbone-blur-001

Primary Prevention of DVT and PE in Acute Spinal Cord Injured Patients

Recommendation 5

We suggest the use of pharmacologic agents and/or mechanical compressive devices for the prevention of venous thromboembolic disease in patients undergoing elective hip or knee arthroplasty, and who are not at elevated risk beyond that of the surgery itself for venous thromboembolism or bleeding.

 

Grade of Recommendation: Moderate

Authors: Seung-Beom Han, MD, PhDa, Yong In, MD, PhDb, Kwang Jun Oh